Keyphrases
Antioxidant Activity
90%
Cancer Cell Lines
77%
Chuquiraga Spinosa
77%
Breast Cancer
77%
Medicinal Plants
73%
Protective Effect
72%
Anti-inflammatory Effect
70%
Ethanolic Extract
67%
N-ethyl-N-nitrosourea
66%
Oral Administration
63%
Total Phenolic Content
62%
Phytochemical Screening
60%
Cytotoxic Activity
58%
Randomized Clinical Trial
58%
Gastric Cancer
58%
Third Molar Surgery
58%
Oral Toxicity
58%
Sacha Inchi
58%
Ethanol Extract
43%
IC50
43%
Peruvian
41%
Preventive Effect
41%
Diclofenac
41%
Anthracene
41%
Female Rats
41%
Histopathological Examination
39%
Oenothera Rosea
38%
Rodents
38%
Plukenetia Volubilis
38%
Linseed
38%
Linum Usitatissimum
38%
Lethal Dose 50 (LD50)
38%
Chromolaena Laevigata
38%
Hematological Parameters
38%
Biochemical Parameters
38%
Cordia Lutea
38%
Essential Oil
38%
Carvacrol
38%
Pain Intensity
38%
Mandibular Third Molar Surgery
38%
Prostate Cancer
37%
Peru
37%
Emergency Department
36%
7,12-dimethylbenz(a)anthracene
33%
DU145
32%
National Hospital
30%
Physiological Saline
29%
Analgesic Consumption
28%
B Vitamins
27%
Lima
27%
Vitamin B1
25%
K562
25%
H460
25%
MCF-7
25%
San Marco
25%
National Universities
25%
No Significant Difference
24%
Lutea
24%
Prostate Carcinogenesis
24%
Linseed Oil
23%
Peruvian Flora
22%
Ethanol
22%
HT-29
22%
Patients with Cancer
22%
Palliative Care
22%
Phytochemical Analysis
21%
Antitumor Effect
21%
Significant Relationship
21%
Cytotoxicity
19%
Dental Students
19%
Murine Model
19%
Vitamin B12
19%
Ketorolac
19%
Pharmacobotany
19%
Vitamin B6
19%
Health Personnel
19%
Waiting Time
19%
Luffa
19%
Healthcare Workers
19%
Annona muricata
19%
Urea
19%
Analgesic Effect
19%
Sociodemographic Characteristics
19%
Musculoskeletal Symptoms
19%
Working Posture
19%
N-methylation
19%
N-nitroso
19%
Peruvian Plants
19%
Healthcare Facilities
19%
Dental Patients
19%
Facial Edema
19%
Orthodontic Tooth Movement
19%
Postsurgical Therapy
19%
Emergency Department Use
19%
Oral Cancer
19%
COVID-19 Pandemic
19%
Freund's Adjuvant
19%
Stress Anxiety
19%
Impact of Event Scale-Revised (IES-R)
19%
Anti-allergic
19%
Pharmacology, Toxicology and Pharmaceutical Science
Antioxidant Capacity
100%
Neoplasm
96%
Cytotoxicity
69%
Holtzman Rat
68%
Medicinal Plant
66%
Phytochemical Screening
60%
Malignant Neoplasm
59%
Randomized Clinical Trial
58%
Dexamethasone
58%
Abdominal Cancer
58%
Breast Cancer
58%
Disease
53%
Nitrosourea
48%
Analgesic Agent
43%
IC50
42%
Diclofenac
41%
Oenothera
38%
Flax
38%
Linseed Oil
38%
Chromolaena
38%
Prostate Cancer
38%
Essential Oil
38%
Anthracene
38%
Antioxidant
34%
Anti-Inflammatory Drug
34%
7,12-Dimethylbenz(a)anthracene
33%
Antiinflammatory Activity
33%
Carcinogenesis
29%
Triacylglycerol
27%
Vitamin B12
24%
Thiamine
24%
Prevalence
24%
Malonaldehyde
23%
ABTS
22%
Superoxide Dismutase
21%
Table Salt
20%
Cordia
19%
Carvacrol
19%
Ketorolac
19%
N-Nitroso-N-Methylurea
19%
Cross-Sectional Study
19%
Mouth Cancer
19%
Generalized Anxiety Disorder
19%
Thyme
19%
Dose Toxicity
19%
Pannus
19%
Experimental Arthritis
19%
Antiulcer Agent
19%
Thiol Group
19%
Senna
19%
Prostate Specific Antigen
19%
Cymbopogon citratus
19%
Antiallergic Drug
19%
Midazolam
19%
Senecio
19%
Nitric Oxide
18%
C Reactive Protein
16%
Flavonoid
16%
Phytochemical
16%
Carrageenan
15%
Face Edema
14%
1,1 Diphenyl 2 Picrylhydrazyl
12%
Alkaline Phosphatase
12%
Glucose 6 Phosphatase
12%
Linum
12%
High Density Lipoprotein Cholesterol
12%
Clinical Trial
12%
Gallic Acid
11%
Fibrosis
11%
Paracetamol
10%
Anticarcinogen
9%
Cytotoxicity Assay
9%
Trismus
9%
Ethanol-Induced Gastric Ulcer
9%
Cyproterone
9%
Prostatic Intraepithelial Neoplasia
9%
Terminal Disease
9%
Chronic Disease
8%
Tablet
7%
Arthritis
7%
Biphenyl
7%
Acute Toxicity
6%
Necrosis
6%
Sulfonic Acid
6%
Geranium
6%
Physalis
6%
Population Study
6%
Medicine and Dentistry
Tumor Cell Line
77%
Antioxidant Capacity
77%
Cytotoxicity
64%
Phytochemical Screening
60%
IC50
42%
Alcohol
40%
Randomized Clinical Trial
38%
Third Molar
38%
Dexamethasone
38%
Malignant Neoplasm
34%
Mandibular Third Molar
32%
Emergency Department
31%
Disease
30%
DPPH
25%
Analgesic Activity
24%
Cyanocobalamin
24%
Thiamine
24%
MCF-7
23%
2,2' Azinobis(3 Ethylbenzothiazoline 6 Sulfonic Acid)
22%
Anodyne
22%
Symptomatic Treatment
21%
Anti-Inflammatory Drug
19%
Antiinflammatory Activity
19%
Diclofenac
19%
Health Care
19%
Health System
19%
Social Group
19%
Systematic Review
19%
Surgery
19%
Patient Health Questionnaire 9
19%
Rural Population
19%
Terminal Illness
19%
Health Service
19%
Impact of Events Scale
19%
COVID-19
19%
Oral Cancer
19%
Orthodontic Tooth Movement
19%
Social Condition
19%
Incisor
19%
Health Care Cost
19%
Epidermal Growth Factor Receptor
19%
Carvacrol
19%
Mammalian Target of Rapamycin
19%
Carcinogenesis
19%
In Silico
19%
Prostate Cancer
19%
Breast Cancer
19%
Antinuclear Antibody
19%
Cell Nucleus Antigen
19%
Connective Tissue Disease
19%
Receptor
19%
Antioxidant
18%
Flavonoid
16%
Face Edema
14%
Phytochemical
14%
Orthodontics
12%
Osteocyte
12%
Alkaline Phosphatase
12%
Osteoblast
12%
Cyproterone
12%
Prostate Specific Antigen
12%
Analgesia
12%
Oxidative Stress
11%
Phenol Derivative
11%
Gallic Acid
11%
Spectrophotometry
11%
Clinical Trial
10%
Anticarcinogen
9%
Clinician
9%
Trismus
9%
Generalized Anxiety Disorder
9%
Prevalence
9%
Multivariate Analysis
9%
Patient Health Questionnaire
9%
Cross Sectional Study
9%
Drug Therapy
9%
Extractable Nuclear Antigens
9%
Chi Square Test
9%
Sulfonic Acid Derivative
6%
Population Research
6%
Histopathology
6%
Body Weight
6%
Prostatic Intraepithelial Neoplasia
6%
Nitrosourea
6%
High-Grade Prostatic Intraepithelial Neoplasia
6%
Intoxication
6%
Pentobarbital
6%
Somatics
6%
Table Salt
6%